{"id":5791,"date":"2024-02-15T17:12:16","date_gmt":"2024-02-15T11:42:16","guid":{"rendered":"https:\/\/gwcindia.in\/blog\/\/?p=5791"},"modified":"2024-08-28T10:44:24","modified_gmt":"2024-08-28T05:14:24","slug":"ipo-zenith-drugs-limited","status":"publish","type":"post","link":"https:\/\/www.gwcindia.in\/blog\/ipo-zenith-drugs-limited\/","title":{"rendered":"IPO : Zenith Drugs Limited"},"content":{"rendered":"<h1>Zenith Drugs Limited IPO<\/h1>\n<table style=\"height: 242px;\" width=\"832\">\n<tbody>\n<tr>\n<td width=\"1788\"><strong>\u00a0SYMBOL<\/strong><\/td>\n<td width=\"1790\"><strong>ZENITHDRUG<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0ISSUE TYPE<\/strong><\/td>\n<td><strong>Book Built Issue IPO<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0ISSUE OPENS ON<\/strong><\/td>\n<td><strong>Monday, February 19, 2024<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0ISSUE CLOSES ON<\/strong><\/td>\n<td><strong>Thursday, February 22, 2024<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0ISSUE PRICE<\/strong><\/td>\n<td><strong>\u20b975 to \u20b979 per share<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0ISSUE SIZE<\/strong><\/td>\n<td><strong>Up to Rs.40.68 Crores<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0FACE VALUE<\/strong><\/td>\n<td><strong>Rs.10 per share<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Zenith Drugs IPO is a book built issue of Rs 40.68 crores. The issue is entirely a fresh issue of 51.49 lakh shares.<\/strong><\/p>\n<p><strong>Zenith Drugs IPO opens for subscription on February 19, 2024 and closes on February 22, 2024. The allotment for the Zenith Drugs IPO is expected to be finalized on Friday, February 23, 2024. Zenith Drugs IPO will list on NSE SME with tentative listing date fixed as Tuesday, February 27, 2024.<\/strong><\/p>\n<table style=\"height: 251px;\" width=\"830\">\n<tbody>\n<tr>\n<td width=\"1788\">\u00a0<strong>MINIMUM BID<\/strong><\/td>\n<td width=\"1790\"><strong>1600 shares<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0MINIMUM AMOUNT\u00a0<\/strong><\/td>\n<td><strong>Rs.126,400<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0MAXIMUM BID<\/strong><\/td>\n<td width=\"1790\"><strong>1600 shares<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0MAXIMUM AMOUNT\u00a0<\/strong><\/td>\n<td><strong>Rs.126,400<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0PROMOTER HOLDING<\/strong><\/td>\n<td><strong>69.98% (Post-issue)<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0LISTING DATE<\/strong><\/td>\n<td><strong>Tuesday, February 27, 2024<\/strong><\/td>\n<\/tr>\n<tr>\n<td><strong>\u00a0LISTING AT<\/strong><\/td>\n<td><strong>NSE-SME<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Zenith Drugs IPO price band is set at \u20b975 to \u20b979 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is \u20b9126,400. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to \u20b9252,800.<\/strong><\/p>\n<h4 class=\"border-bottom\">Objects of the Issue (Zenith Drugs IPO Objectives)<\/h4>\n<p><strong>The Company intends to utilize the Net Fresh Issue Proceeds for the following Objects<\/strong><\/p>\n<ul>\n<li><strong>Purchase of Machinery &amp; Equipments for Setting up New Unit<\/strong><\/li>\n<li><strong>Existing Manufacturing Block Upgradation<\/strong><\/li>\n<li><strong>Working Capital Requirements<\/strong><\/li>\n<li><strong>General Corporate Purposes.<\/strong><\/li>\n<\/ul>\n<div>\n<div><\/div>\n<div><\/div>\n<div><strong>SMART IPO using UPI, you can now apply online<\/strong><\/div>\n<\/div>\n<div>\n<p><strong>For Existing Clients :\u00a0<a href=\"https:\/\/gudwil.in\/IPO\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/gudwil.in\/IPO<br \/>\n<\/a>Open an account : \u00a0<a href=\"https:\/\/gudwil.in\/smart\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/gudwil.in\/smart<\/a><\/strong><\/p>\n<p><strong>Further any clarification, feel free to contact your Branch \/ Relationship Manager.For all your investment needs feel free to reach us. Give us a missed call at 90037 90027. For Support: 044-40329999<\/strong><\/p>\n<p><strong>Warm Regards,<\/strong><\/p>\n<p><strong>Team GoodwillDISCLAIMER :\u00a0Investments in the securities market are subject to market risk. Read all the related documents carefully before investing. The data and information herein provided are believed to be reliable, but Goodwill Wealth Management Pvt. Ltd., does not warrant its accuracy or completeness. Goodwill Wealth Management Pvt. Ltd., or any of its employees are not liable for any action taken by any party based on the above information. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Special note: Short-term trading on the basis of technical is high risk and skill-oriented venture and may result in huge losses also. Traders doing so are doing at their own risk. We are not responsible for any damages. Note: The material is being provided to you for educational purposes only and does not constitute investment advice; returns mentioned herein are in no way a guarantee or promise of future returns. See Disclaimer, Privacy Policy @\u00a0<a href=\"https:\/\/www.gwcindia.in\/Disclaimer\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.gwcindia.in\/Disclaimer<\/a><\/strong><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Zenith Drugs Limited IPO \u00a0SYMBOL ZENITHDRUG \u00a0ISSUE TYPE Book Built Issue IPO \u00a0ISSUE OPENS ON Monday, February 19, 2024 \u00a0ISSUE CLOSES ON Thursday, February 22, 2024 \u00a0ISSUE PRICE \u20b975 to \u20b979 per share \u00a0ISSUE SIZE Up to Rs.40.68 Crores \u00a0FACE VALUE Rs.10 per share Zenith Drugs IPO is a book built issue of Rs 40.68 [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5792,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[117],"tags":[],"class_list":["post-5791","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-ipo","post_format-post-format-image"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/posts\/5791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/comments?post=5791"}],"version-history":[{"count":0,"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/posts\/5791\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/media\/5792"}],"wp:attachment":[{"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/media?parent=5791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/categories?post=5791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gwcindia.in\/blog\/wp-json\/wp\/v2\/tags?post=5791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}